A new modelling study from RespiCompass, the ECDC Respiratory Diseases Scenario Modelling Hub, indicates that influenza and COVID-19 vaccination programmes markedly reduced hospitalisations among older adults across Europe in the 2024/25 season.

In partnership with ESWI, the Coalition for Life Course Immunisation has released a new policy brief highlighting the urgent need for a more coordinated, life-course approach to respiratory virus prevention across the EU.

Check out this Satellite Symposium organised by the ESWI IDC and supported by IFPMA and Sanofi from ESWI2026.

It’s difficult to predict just how severe the influenza season will be each year, but public health experts say it could be harsh in Europe due to lagging vaccination rates and early signals from far-flung countries such as Japan and Australia.

The Steering Group on the Prevention of Respiratory Infections launched a new manifesto at the #EURespiDay event held at the European Parliament in Brussels

As COVID-19 transitions from a pandemic to an endemic disease, its integration into the broader policy and healthcare framework for respiratory diseases becomes imperative.

This year, 15 October marks the evolution of #EUFluDay into #EURespiDay, a broader call for EU action on respiratory infection prevention.

Mucosal vaccines are designed to elicit both a strong systemic and mucosal immune response gaining importance as the next generation of vaccines